@article{JTD22976,
author = {Ying Chen and Junping Gong and Huiming Zhou and Xiujuan Qu and Yuee Teng and Yunpeng Liu and Bo Jin},
title = {Apatinib for EGFR-TKI and chemotherapy refractory in an advanced lung cancer patient: a case report},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {7},
year = {2018},
keywords = {},
abstract = {In China, primary lung cancer is one of the most common malignant tumors. The data of China Cancer Center in 2015 showed that the prevalence of lung cancer was 130.2 (1/10 million) from 2006 to 2011 in China. And lung cancer has risen to be the fourth leading cause of death (1). Most patients have distant metastasis when they get initial diagnosis.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/22976}
}